Gland Pharma Ltd

Registered Office: Sy No 143-148 150&151 Nr Gandi,X Roads D P Pally Dundigal, Hyderabad - 500043, Telangana, India. Phone : 91-40-30510999   Fax:91-40-30510800 Email : investors@glandpharma.com Website :www.glandpharma.com

Initial public offer of 43196968 equity shares of face value of Re. 1 each ("equity shares") of Gland Pharma Limited ("Company" or "Issuer") for cash at a price of Rs.1500 Per equity share (including a share premium of Rs.1499 per equity share) aggregating Rs.6479.55 crores (The "Offer") comprising a fresh issue of 8,333,333 equity shares aggregating up to Rs. 1250 crores on (The "fresh issue") and an offer for sale of 34,863,635 equity shares, including 19,368,686 equity shares by Fosun Pharma Industrial Pte. Ltd ("promoter selling shareholder") and 10,047,435 equity shares by Gland Celsus Bio Chemicals Private Limited, 3,573,014 equity shares By Empower Discretionary Trust, and 1,874,500 equity shares by Nilay Discretionary Trust (collectively, the "other selling shareholders" and collectively With the promoter selling shareholder are referred to as the "selling shareholders", and such equity shares, the "offered shares") aggregating up to Rs. 5229.55 crores (the "offer for sale"). The offer shall constitute 26.46% of the post-offer paid-up equity share capital of the company. The face value of Equity shares is Re.1 each. The offer price is Rs.1500 per equity share and is 1500 times the face value of the Equity Shares. The Anchor Investor Offer Price is Rs.1500 per Equity Share. Issue Opens On Closes On 09-Nov-20 11-Nov-20 Money Payable On Application Allotment 1500.00 0.00 Minimum Application for shares in Nos : 10 Further Multiples of : 10 RsCr Lead Managers to the Issue Project Cost (Rs.Cr) 1250.00 Citigroup Global Markets India Pvt Ltd Project Financed through Current Offer (Rs.Cr) 6479.55   Post Issue Equity Share Capital (Rs.Cr) 163.28 Issue Price (Rs) 1500.00

Projects

Funding incremental working capital requirements of the company Funding capital expenditure requirements of the company General corporate purposes

Promoted By

Fosun Pharma Indust. Pte. Ltd

Shanghai Fosun Pharma. Group

Listing At

BSE

NSE

Registrar to the Issue

No Data Available